Zobrazeno 1 - 10
of 468
pro vyhledávání: '"Toripalimab"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeThis research intends to investigate the treatment of non-small cell lung cancer (NSCLC) using Toripalimab, focusing on its effectiveness and safety profile. Efficacy refers to the survival prognosis, while safety pertains to the occurrence of
Externí odkaz:
https://doaj.org/article/95fe3df6de374cb9bd7f49f110b19d39
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Several immune checkpoint inhibitors (ICIs) have been linked to the occurrence of Vogt-Koyanagi-Harada disease (VKHD)-like uveitis. Among the ICIs, there has been no report of immune-related adverse events (irAEs) caused by a new
Externí odkaz:
https://doaj.org/article/7b3510b0118443cda7c969e77b208cfb
Autor:
Xinrong Hu, Lin Deng, Yufei Pan, Guozhen Zhang, Xiaolan Ruan, Xinlan Jiang, Hao Shen, Lei Zhao, Jun Dong
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundSarcomatoid urothelial carcinoma (SUC) is a rare renal malignancy. Its biological malignancy is high, the prognosis is poor, diagnostic and treatment options are few, and there is no standard treatment plan.Case presentationIn this case, a
Externí odkaz:
https://doaj.org/article/8b6fb2fab37e4deb8792fdc95342b4f2
Autor:
Ruixi Wang, Yihong Ling, Baoqing Chen, Yujia Zhu, Yonghong Hu, Mengzhong Liu, Yadi Yang, Li Zhang, Yingxin Lv, Shiliang Liu, Qiaoqiao Li, Mian Xi
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102806- (2024)
Summary: Background: In the EC-CRT-001 phase II study, the combination of toripalimab (an anti-programmed death-1 antibody) and definitive chemoradiotherapy (CRT) has shown promising efficacy in patients with locally advanced oesophageal squamous cel
Externí odkaz:
https://doaj.org/article/5abb1b5ed4e046c99cc4e51b1298e8f3
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
ObjectiveThis study focuses on assessing the cost-effectiveness of incorporating toripalimab alongside chemotherapy for the treatment of patients diagnosed with metastatic triple-negative breast cancer from the perspective of the Chinese healthcare s
Externí odkaz:
https://doaj.org/article/9ae1ac0befcf4b3f821d5a6f47396e7f
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 3, Pp 348-353 (2024)
Objective To investigate the application and effects of apatinib mesylate combined with programmed death receptor-1 (PD-1) monoclonal antibody (mAb)—toripalimab in immunotherapy for triple negative breast cancer (TNBC). Methods Among 40 female BALB
Externí odkaz:
https://doaj.org/article/0dd5099066424fc3961067638248e73e
Publikováno v:
Cancer Medicine, Vol 13, Iss 10, Pp n/a-n/a (2024)
Abstract Background Toripalimab, combined with gemcitabine and cisplatin, has been approved as the first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma (RM‐NPC), representing a significant milestone as the first FDA‐approve
Externí odkaz:
https://doaj.org/article/5670c4d8b82d45e7a8963142f094d190
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundLocoregionally advanced nasopharyngeal carcinoma (NPC) is an epithelial malignancy that primarily occurs in East and Southeast Asia, and it is associated with relatively poor overall survival (OS). Currently, there is no reliably effective
Externí odkaz:
https://doaj.org/article/40e8d931d76741029849d1aa21076eca
Autor:
Zhenyu Wen, Junxiao Wang, Bo Tu, Yane Liu, Yuqing Yang, Li Hou, Xiang Yang, Xiaoyan Liu, Hui Xie
Publikováno v:
Cancer Medicine, Vol 12, Iss 20, Pp 20311-20320 (2023)
Abstract Objective The effectiveness and security of radiofrequency ablation (RFA) in combination with toripalimab (anti‐PD‐1) for the treatment of recurrent hepatocellular carcinoma (HCC) was studied in this article. Methods Total of 40 patients
Externí odkaz:
https://doaj.org/article/ebf45b46a35b48c7bd644f29d77efbc3
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder is a rare malignancy. With its high aggressiveness and poor prognosis, the disease is often accompanied by metastasis or recurrence. The lack of specific clinical manife
Externí odkaz:
https://doaj.org/article/fe2ac7b5d3b14061837fa2298819eade